GSK Investigational Site

Gières 38610

0 studies enrolling now · 5 studies all time

What they study most

Asthma, Atherosclerosis, Diabetes Mellitus, Type 2

Studies at this site

• A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects — Completed
• A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects — Completed
• A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes — Completed
• Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma — Completed
• SB-480848 In Subjects With Coronary Heart Disease — Completed